Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic ratsLen Verbeke, Wim Laleman|Hepatology|2013Cited by 257
Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failureWim Laleman, Frederik Nevens, Zahur Zaman et al.|Critical Care|2006Cited by 249
Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling studyMathias Jachs, Aitor Odriozola, Fanny Turón et al.|The Lancet. Gastroenterology & hepatology|2024Cited by 69